drugset
Drugs / ROCACETRAPIB
last change Jan 2018 re-read 2 minutes ago

ROCACETRAPIB

also known as CKD-519 · CKD-519 FDI

Small molecule targets CETP via inhibition

Developed for
hyperlipidemia
Investigated by
Chong Kun Dang Pharmaceutical

Trials 9 · a red edge is where a trial was stopped

today NCT03175835 · Ph 1 NCT02977065 · Ph 2 NCT03210649 · Ph 1 NCT02894541 · Ph 1 NCT02916901 · Ph 1 NCT02753504 · Ph 1 NCT02623868 · Ph 1 NCT02484482 · Ph 1 NCT02156544 · Ph 1
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 18 trials
Phase 1 NCT03175835 May → Jun 2017 hyperlipidemia Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT03210649 Mar → Apr 2017 hyperlipidemia Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT02894541 Aug → Nov 2016 — Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT02916901 Aug → Oct 2016 — Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT02753504 Apr → Jul 2016 hyperlipidemia Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT02623868 Oct → Dec 2015 hyperlipidemia Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT02484482 Jun → Aug 2015 hyperlipidemia Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 1 NCT02156544 Jun → Oct 2014 hyperlipidemia Chong Kun Dang Pharmaceutical Completed No outcome recorded
Phase 21 trial
Phase 2 NCT02977065 Mar → Dec 2017 hyperlipidemia Chong Kun Dang Pharmaceutical Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 10 sources stand behind the page.

FieldValueCited text
Known as ROCACETRAPIB ChEMBL registry synonym — accepted as the source's own label CHEMBL4297601 ↗
Known as CKD-519 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02156544 ↗
8

NCT02623868 ↗

NCT03175835 ↗

NCT02916901 ↗

NCT02977065 ↗

NCT02894541 ↗

NCT03210649 ↗

NCT02484482 ↗

NCT02753504 ↗
Known as CKD-519 FDI “CKD-519(CKD-519 FDI)” NCT02484482 ↗
Action Inhibit “CETP inhibitor CKD-519” NCT02977065 ↗
Modality Small molecule — CHEMBL4297601 ↗
Route Oral “After Oral Administration” NCT02156544 ↗
Target CETP “cholesteryl ester transfer protein (CETP) inhibitor CKD-519” NCT02977065 ↗